HomeCompareMSOX vs JNJ

MSOX vs JNJ: Dividend Comparison 2026

MSOX yields 93.02% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MSOX wins by $2.90M in total portfolio value
10 years
MSOX
MSOX
● Live price
93.02%
Share price
$2.15
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$2.92M
Annual income
$936,405.38
Full MSOX calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — MSOX vs JNJ

📍 MSOX pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodMSOXJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, MSOX + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
MSOX pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

MSOX
Annual income on $10K today (after 15% tax)
$7,906.98/yr
After 10yr DRIP, annual income (after tax)
$795,944.57/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, MSOX beats the other by $795,240.96/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of MSOX + JNJ for your $10,000?

MSOX: 50%JNJ: 50%
100% JNJ50/50100% MSOX
Portfolio after 10yr
$1.47M
Annual income
$468,616.58/yr
Blended yield
31.92%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

MSOX
No analyst data
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

MSOX buys
0
JNJ buys
0
No recent congressional trades found for MSOX or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricMSOXJNJ
Forward yield93.02%3.36%
Annual dividend / share$2.00$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR0%5.8%
Portfolio after 10y$2.92M$20.0K
Annual income after 10y$936,405.38$827.78
Total dividends collected$2.58M$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: MSOX vs JNJ ($10,000, DRIP)

YearMSOX PortfolioMSOX Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$20,002$9,302.33$10,676$355.77+$9.3KMSOX
2$38,792$17,389.55$11,407$389.39+$27.4KMSOX
3$73,026$31,518.57$12,198$426.53+$60.8KMSOX
4$133,590$55,452.10$13,056$467.62+$120.5KMSOX
5$237,746$94,804.79$13,987$513.12+$223.8KMSOX
6$412,072$157,683.40$14,998$563.56+$397.1KMSOX
7$696,341$255,423.97$16,098$619.52+$680.2KMSOX
8$1,148,476$403,391.61$17,295$681.69+$1.13MMSOX
9$1,850,659$621,789.37$18,599$750.82+$1.83MMSOX
10$2,916,610$936,405.38$20,022$827.78+$2.90MMSOX

MSOX vs JNJ: Complete Analysis 2026

MSOXStock

The fund will enter into one or more swap agreements intended to produce economically-leveraged investment results relative to the returns of the US Cannabis ETF. The US Cannabis ETF primarily invests in exchange-listed equity securities, including common and preferred stock, of mid- and small-capitalization companies, and in total return swaps intended to provide exposure to such companies. The fund is non-diversified.

Full MSOX Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this MSOX vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

MSOX vs SCHDMSOX vs JEPIMSOX vs OMSOX vs KOMSOX vs MAINMSOX vs ABBVMSOX vs MRKMSOX vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.